Pfizer, the world’s largest drugmaker, took a $2.3 billion charge for a record settlement of U.S. investigations into improper marketing of its Bextra painkiller and other drugs. Pfizer reached an agreement with the U.S. attorney in Massachusetts to “resolve previously ...
Tagged with: Bextra painkiller drugmaker Eli Lilly & Co. improper marketing investigation Pfizer settlement
Read More »